We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.64B
AUM Growth
-$53.3M
Cap. Flow
-$136M
Cap. Flow %
-5.13%
Top 10 Hldgs %
36.54%
Holding
1,168
New
94
Increased
480
Reduced
555
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.36M
2
SMCI icon
Super Micro Computer
SMCI
+$2.38M
3
MRNA icon
Moderna
MRNA
+$2.02M
4
COP icon
ConocoPhillips
COP
+$1.81M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.72M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$50.2M
2
MSFT icon
Microsoft
MSFT
+$20.1M
3
AVGO icon
Broadcom
AVGO
+$9.06M
4
META icon
Meta Platforms (Facebook)
META
+$6.04M
5
AMZN icon
Amazon
AMZN
+$5.57M

Sector Composition

Rank Sector Weight
1 Technology 43.4%
2 Healthcare 11.97%
3 Consumer Discretionary 10.33%
4 Communication Services 9.11%
5 Financials 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIT icon
1076
Wipro
WIT
$18.5B
$161K 0.01%
49,560
-6,112
-11% -$19.1K
AVXL icon
1077
Anavex Life Sciences
AVXL
$222M
$159K 0.01%
27,973
-13,307
-32% -$76.8K
TNGX icon
1078
Tango Therapeutics
TNGX
$4.34B
$158K 0.01%
20,473
+6,580
+47% +$62.8K
CWK icon
1079
Cushman & Wakefield Ltd
CWK
$2.98B
$158K 0.01%
11,565
+1,469
+15% +$18.5K
OCGN icon
1080
Ocugen
OCGN
$410M
$155K 0.01%
156,167
+9,525
+6% +$13.1K
RES icon
1081
RPC Inc
RES
$1.24B
$152K 0.01%
23,889
-8,240
-26% -$51.9K
CLF icon
1082
Cleveland-Cliffs
CLF
$6.81B
$152K 0.01%
11,869
-458
-4% -$6.22K
FATE icon
1083
Fate Therapeutics
FATE
$281M
$149K 0.01%
42,652
-3,876
-8% -$15.1K
GNW icon
1084
Genworth Financial
GNW
$3.8B
$149K 0.01%
21,774
+789
+4% +$5.19K
ALTM
1085
DELISTED
Arcadium Lithium plc
ALTM
$149K 0.01%
52,201
+1,915
+4% +$5.54K
LXP icon
1086
LXP Industrial Trust
LXP
$3.53B
$149K 0.01%
2,956
+144
+5% +$7.19K
SVRA icon
1087
Savara
SVRA
$1.13B
$145K 0.01%
34,215
+8,198
+32% +$36.2K
NMRA icon
1088
Neumora Therapeutics
NMRA
$276M
$143K 0.01%
+10,828
New +$126K
MDXG icon
1089
MiMedx Group
MDXG
$626M
$139K 0.01%
23,516
-3,379
-13% -$22.4K
ORIC icon
1090
Oric Pharmaceuticals
ORIC
$1.25B
$138K 0.01%
13,502
-8,359
-38% -$82.6K
AG icon
1091
First Majestic Silver
AG
$8.05B
$135K 0.01%
22,548
+837
+4% +$4.85K
HBI
1092
DELISTED
Hanesbrands
HBI
$131K ﹤0.01%
17,785
+867
+5% +$5.19K
ERAS icon
1093
Erasca
ERAS
$6.63B
$130K ﹤0.01%
+47,626
New +$134K
LQDA icon
1094
Liquidia Corp
LQDA
$7.67B
$129K ﹤0.01%
12,942
-1,492
-10% -$16.3K
FULC icon
1095
Fulcrum Therapeutics
FULC
$248M
$124K ﹤0.01%
34,846
+23,925
+219% +$177K
ATXS
1096
DELISTED
Astria Therapeutics
ATXS
$122K ﹤0.01%
11,038
-9,361
-46% -$104K
DFTX
1097
Definium Therapeutics
DFTX
$5.73B
$119K ﹤0.01%
20,843
-3
-0% -$21
GT icon
1098
Goodyear
GT
$2.07B
$117K ﹤0.01%
13,185
+127
+1% +$1.2K
AUR icon
1099
Aurora
AUR
$11.7B
$116K ﹤0.01%
19,584
+2,834
+17% +$11.8K
PLRX icon
1100
Pliant Therapeutics
PLRX
$67.5M
$113K ﹤0.01%
+10,077
New +$126K
42 43
44
45 46

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Profund Advisors held 1,168 positions worth $2.64B, down 2% from $2.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Profund Advisors withdrew a net $136M in Q3 2024, closing 36 positions and reducing 555 holdings. Its most notable exit was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $1.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Palantir worth $1.57M.

  • Profund Advisors's largest Q3 2024 buy was Palantir: 42,137 shares worth $1.57M.
  • Profund Advisors added most to Apple in Q3 2024, an estimated $4.36M increase.
  • Profund Advisors's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $50.2M.
  • Profund Advisors fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $1.33M.
  • Profund Advisors's ten largest holdings make up 37% of its $2.64B portfolio in Q3 2024.
  • Profund Advisors opened 94 new positions and closed 36 in Q3 2024.
  • Profund Advisors's portfolio value fell 2% quarter-over-quarter to $2.64B.

Based on Profund Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.